LUP Statistics
Record
- Title
- Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases
- Type
- Journal Article
- Publ. year
- 2010
- Author/s
- Martini, Paolo G. V.; Cook, Lynette C.; Alderucci, Scott; Norton, Angela W. et al.
- Department/s
- Division of Microbiology, Immunology and Glycobiology - MIG; Rheumatology
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 380 | 8 | 1 |
United States of America  |
242 (64%) |
Czechia  |
24 (6%) |
Germany  |
23 (6%) |
China  |
19 (5%) |
Russian Federation  |
16 (4%) |
Sweden  |
13 (3%) |
United Kingdom of Great Britain and Northern Ireland  |
7 (2%) |
Hong Kong (China)  |
5 (1%) |
Ukraine  |
4 (1%) |
France  |
3 (1%) |
Australia  |
3 (1%) |
Ireland  |
2 (1%) |
India  |
2 (1%) |
South Africa  |
2 (1%) |
Canada  |
1 (0%) |
Singapore  |
1 (0%) |
United Arab Emirates  |
1 (0%) |
Denmark  |
1 (0%) |
Iran  |
1 (0%) |
Hungary  |
1 (0%) |
Belgium  |
1 (0%) |
Netherlands (Kingdom of the)  |
1 (0%) |
Spain  |
1 (0%) |
New Zealand  |
1 (0%) |
Poland  |
1 (0%) |
Yemen  |
1 (0%) |
European Union location  |
1 (0%) |
Turkiye  |
1 (0%) |
South Korea  |
1 (0%) |